Literature DB >> 17459939

Epstein-barr virus: environmental trigger of multiple sclerosis?

Jan D Lünemann1, Thomas Kamradt, Roland Martin, Christian Münz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17459939      PMCID： PMC1933281          DOI： 10.1128/JVI.00153-07

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  86 in total

1.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

Authors:  Casper Paludan; Dorothee Schmid; Markus Landthaler; Martina Vockerodt; Dieter Kube; Thomas Tuschl; Christian Münz
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

3.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Authors:  R G Caldwell; J B Wilson; S J Anderson; R Longnecker
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

4.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

5.  T cell selection during the evolution of CD8+ T cell memory in vivo.

Authors:  M F Callan; N Annels; N Steven; L Tan; J Wilson; A J McMichael; A B Rickinson
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

6.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

Authors:  L C Tan; N Gudgeon; N E Annels; P Hansasuta; C A O'Callaghan; S Rowland-Jones; A J McMichael; A B Rickinson; M F Callan
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

Review 7.  Immunology of multiple sclerosis.

Authors:  Mireia Sospedra; Roland Martin
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

8.  CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.

Authors:  H M Long; T A Haigh; N H Gudgeon; A M Leen; C-W Tsang; J Brooks; E Landais; E Houssaint; S P Lee; A B Rickinson; G S Taylor
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

10.  Defective B cell tolerance checkpoints in systemic lupus erythematosus.

Authors:  Sergey Yurasov; Hedda Wardemann; Johanna Hammersen; Makoto Tsuiji; Eric Meffre; Virginia Pascual; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307
View more
  37 in total

1.  Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Rajiv T Erasmus; Tandi E Matsha
Journal:  Metab Brain Dis       Date:  2012-03-10       Impact factor: 3.584

2.  Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.

Authors:  Laura Angelici; Mirko Piola; Tommaso Cavalleri; Giorgia Randi; Francesca Cortini; Roberto Bergamaschi; Andrea A Baccarelli; Pier Alberto Bertazzi; Angela Cecilia Pesatori; Valentina Bollati
Journal:  Environ Res       Date:  2015-12-06       Impact factor: 6.498

3.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

4.  Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.

Authors:  Marwa Shehab; Nour Sherri; Hadi Hussein; Noor Salloum; Elias A Rahal
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

6.  Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.

Authors:  Simon N Willis; Christine Stadelmann; Scott J Rodig; Tyler Caron; Stefan Gattenloehner; Scott S Mallozzi; Jill E Roughan; Stefany E Almendinger; Megan M Blewett; Wolfgang Brück; David A Hafler; Kevin C O'Connor
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

7.  Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays.

Authors:  Jessica Wong; Sahar Sibani; Naa Norkor Lokko; Joshua LaBaer; Karen S Anderson
Journal:  J Immunol Methods       Date:  2009-09-02       Impact factor: 2.303

8.  Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.

Authors:  Jan D Lünemann; Oliver Frey; Thorsten Eidner; Michael Baier; Susanne Roberts; Junji Sashihara; Rudolf Volkmer; Jeffrey I Cohen; Gert Hein; Thomas Kamradt; Christian Münz
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 9.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.